» Articles » PMID: 38782259

Re: Persistent COVID-19 in Immunocompromised Patients-Israeli Society of Infectious Diseases Consensus Statement on Diagnosis and Management by Meijer Et al

Overview
Publisher Elsevier
Date 2024 May 23
PMID 38782259
Authors
Affiliations
Soon will be listed here.
Citing Articles

Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis.

Maria M, Maraolo A, Cozzolino C, Sasset L, Ferrari A, Basso M Eur J Med Res. 2024; 29(1):484.

PMID: 39367485 PMC: 11451216. DOI: 10.1186/s40001-024-02062-5.